Skip to main content
. 2018 Jul 10;24(5):278–284. doi: 10.1177/1753425918785715

Figure 2.

Figure 2.

Viability of IEC-6 cells treated with increasing doses of human breast milk-derived exosomes. *P < 0.05 using post hoc Dunnett's test. Bright-field images of IEC-6 cells were taken at 10× magnification. (a) Control, (b) exosome concentration of 0.1 µg, (c) exosome concentration of 1 µg, (d) exosome concentration of 10 µg.